Larvol Delta - Aro-Biotherapeutics-Announces-US-FDA-Clearance-of-IND-Application-for-ABX1100-for-Potential-Treatment-of-LateOnset-Pompe-Disease-LOPD

ABX1100 - Aro Biotherap

https://www.businesswire.com/news/home/20250205483983/en/Aro-Biotherapeutics-Announces-U.S.-FDA-Clearance-of-IND-Application-for-ABX1100-for-Potential-Treatment-of-Late-Onset-Pompe-Disease-LOPD

Feb 5, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next